術中神經監測市場規模、佔有率、成長分析、按產品和服務、按來源類型、按應用、按模式、按最終用戶、按地區 - 行業預測，2024-2031 年

2022 年，術中神經監測的全球市場規模為 31.2 億美元，從 2023 年的 32.7 億美元成長到 2031 年的 47.6 億美元，預計在預測期內（2024-2031 年）將成長。成長率為4.8%。

由於術中神經監測在手術期間即時監測和評估神經系統方面發揮的關鍵作用，預計 2022 年至 2030 年全球術中神經監測市場的複合年成長率將達到 4.9%。這項創新技術對於有效評估神經系統的完整性和功能至關重要，特別是在可能損害大腦、脊髓和周圍神經的高風險手術中。術中神經監測包括各種技術，例如肌電圖、腦電圖和誘發電位。在患者安全意識增強和技術進步的推動下，市場預計將成長。此外，中風、癲癇、阿茲海默症和帕金森氏症等慢性神經系統疾病的發生率不斷上升，進一步增加了對神經監測解決方案的需求。世界衛生組織 (WHO) 透露，全球每年約有 1500 萬人經歷中風，凸顯了全球需要更強大的監測設備。術中神經監測市場也預計將保持穩健的成長軌跡，這反映出美國日益重視複雜外科手術中的病患安全，以及神經監測在改善手術結果和增強病患整體體驗方面的重要性。技術創新、意識提高和神經系統疾病流行等累積因素可能在未來幾年推動術中神經監測市場強勁發展。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 市場生態系統
• 貿易分析
• 供應鏈分析
• 案例研究分析
• 專利分析
• 客戶和購買標準分析
• 監管環境
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 競爭程度

術中神經監測市場：依產品及服務分類

• 市場概況
• 系統
• 配件
• 服務

術中神經監測市場：依來源類型

• 市場概況
• 內部監控
• 外部監測

術中神經監測市場：依應用分類

• 市場概況
• 脊椎手術
• 神經外科
• 整形外科手術
• 耳鼻喉科手術
• 血管外科
• 其他手術

術中神經監測市場：依方式分類

• 市場概況
• 運動誘發電位 (MEP)
• 體感誘發電位 (SSEP)
• 腦電圖（EEG）
• 肌電圖（EMG）
• 腦幹聽覺誘發電位 (BAEP)
• 視覺誘發電位（VEP）

術中神經監測市場：依最終使用者分類

• 市場概況
• 醫院
• 日間手術中心 (ASC)

按地區分類的術中神經監測市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Natus Medical Incorporated（US）
• Accurate Monitoring（US）
• Neuromonitoring Technologies（US）
• Medtronic（Ireland）
• NuVasive, Inc.（US）
• SpecialtyCare（US）
• Cadwell Industries, Inc.（US）
• Alpha Omega Engineering, Inc.（US）
• Biotronic NeuroNetwork（US）
• IntraOp Medical Corporation（US）
• NeuroWave Systems, Inc.（US）
• Integra LifeSciences Corporation（US）
• Zynex, Inc.（US）
• Medtronic（Ireland）
• Stryker Corporation（US）
• Nerve Monitoring Services, Inc.（US）
• Neurodiagnostic Services（US）
• Aesculap, Inc.（US）
• Elekta AB（Sweden）
• OrLive（US）
• Stimwave Technologies（US）

Global Intraoperative Neuromonitoring Market size was valued at USD 3.12 billion in 2022 and is poised to grow from USD 3.27 billion in 2023 to USD 4.76 billion by 2031, growing at a CAGR of 4.8% during the forecast period (2024-2031).

The global intraoperative neuromonitoring market is projected to experience a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030, driven by its critical role in real-time monitoring and assessment of the nervous system during surgeries. This innovative technique is essential for the effective evaluation of the integrity and function of the nervous system, particularly in high-risk operations that may jeopardize the brain, spinal cord, and peripheral nerves. Intraoperative neuromonitoring encompasses various techniques, including electromyography, electroencephalography, and evoked potentials. The market is poised for growth, fueled by increasing awareness of patient safety and advancements in technology. Additionally, the rising incidence of chronic neurological disorders, such as stroke, epilepsy, Alzheimer's, and Parkinson's disease, further underscores the demand for neuromonitoring solutions. The World Health Organization highlights that approximately 15 million people worldwide experience a cerebral stroke annually, highlighting the global need for enhanced monitoring devices. In the United States, the intraoperative neuromonitoring market is also expected to sustain a robust growth trajectory, reflecting a growing emphasis on patient safety during complex surgical procedures, underscoring the importance of neuromonitoring in improving surgical outcomes and enhancing the overall patient experience. The cumulative factors of technological innovation, heightened awareness, and the prevalence of neurological disorders are set to firmly propel the intraoperative neuromonitoring market forward in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intraoperative Neuromonitoring market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intraoperative Neuromonitoring Market Segmental Analysis

Global Intraoperative Neuromonitoring Market is segmented by Products and Services, Source Type, Application, Modality, End User, and region. Based on Products and Services, the market is segmented into Systems, Accessories, and Services. Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Other surgeries. Based on Modality, the market is segmented into Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem auditory evoked potentials (BAEPs), and Visual evoked potentials (VEPs). Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Intraoperative Neuromonitoring Market

The global intraoperative neuromonitoring market is experiencing robust growth driven by the increasing aging population, which is more vulnerable to chronic illnesses like heart disease, diabetes, and neurological disorders. As healthcare providers aim to enhance surgical outcomes and patient safety, advanced neurosurgery devices and less invasive surgical technologies are becoming essential. Innovations such as the NIM Vital system provide real-time nerve status information, optimizing surgical strategies and improving patient quality of life. Furthermore, the rising trend of medical tourism and escalating healthcare investments in developing regions present lucrative opportunities, while chronic health challenges driven by modern lifestyles further stimulate demand for neuromonitoring solutions.

Restraints in the Global Intraoperative Neuromonitoring Market

The Global Intraoperative Neuromonitoring (IONM) market faces significant restraints primarily due to the high costs associated with IONM devices and procedures. Prices for EEG devices range from US$ 1,000 to over US$ 25,000, creating budget challenges for healthcare facilities, leading many to opt for refurbished devices rather than investing in new technology. Additionally, a shortage of trained professionals to manage and maintain these advanced monitoring systems further hampers market growth. Compounding these issues is the lack of awareness regarding the benefits of IONM, especially in developing economies, which restricts adoption and ultimately limits market expansion.

Market Trends of the Global Intraoperative Neuromonitoring Market

The Global Intraoperative Neuromonitoring (IONM) market is experiencing a significant upward trend post-pandemic, fueled by a resurgence in elective surgeries and heightened awareness of IONM's benefits to patient safety and surgical outcomes. Technological advancements in IONM equipment are further driving this market, offering improved accuracy and ease of use, which enhances the affordability and accessibility of these services. As healthcare providers increasingly incorporate IONM into surgical protocols, the market is poised for robust growth, reflecting a collective shift towards enhanced patient monitoring and safety during surgical procedures worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Intraoperative Neuromonitoring Market by Products and Services

• Market Overview
• Systems
• Accessories
• Services

Intraoperative Neuromonitoring Market by Source Type

• Market Overview
• Insourced Monitoring
• Outsourced Monitoring

Intraoperative Neuromonitoring Market by Application

• Market Overview
• Spinal Surgery
• Neurosurgery
• Orthopedic Surgery
• ENT Surgery
• Vascular Surgery
• Other surgeries

Intraoperative Neuromonitoring Market by Modality

• Market Overview
• Motor evoked potentials (MEPs)
• Somatosensory evoked potentials (SSEPs)
• Electroencephalography (EEG)
• Electromyography (EMG)
• Brainstem auditory evoked potentials (BAEPs)
• Visual evoked potentials (VEPs)

Intraoperative Neuromonitoring Market by End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)

Intraoperative Neuromonitoring Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Natus Medical Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accurate Monitoring (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuromonitoring Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SpecialtyCare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Industries, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpha Omega Engineering, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronic NeuroNetwork (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntraOp Medical Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroWave Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zynex, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nerve Monitoring Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurodiagnostic Services (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrLive (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments